Autologous Cell Therapy Market - Global Outlook and Forecast 2022-2028

February 2022 | 60 pages | ID: AEFA7515108BEN
Market Monitor Global

Abstracts

Autologous cell therapy refers to the injection or delivery of human tissue or cells to the same person to treat pathological conditions. For the same purpose, the stem cells are taken out of the patient, harvested, cultured, and transplanted again to the same person. The purpose of this method is to reduce the chance of rejecting treatment in the body. In addition, autologous cell therapy does not require immunosuppression.

This report contains market size and forecasts of Autologous Cell Therapy in Global, including the following market information:

Global Autologous Cell Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Autologous Cell Therapy market was valued at 7441.3 million in 2021 and is projected to reach US$ 16310 million by 2028, at a CAGR of 11.9% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Bone Marrow Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Autologous Cell Therapy include BioTime, Pharmicell, BrainStorm Cell Therapeutics, Opexa Therapeutics, Vericel Corporation and Regeneus, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Autologous Cell Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Autologous Cell Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Autologous Cell Therapy Market Segment Percentages, by Type, 2021 (%)

• Bone Marrow
• Epidermis

Global Autologous Cell Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Autologous Cell Therapy Market Segment Percentages, by Application, 2021 (%)

• Neurology
• Orthopedics
• Cancer
• Wound Healing
• Other

Global Autologous Cell Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Autologous Cell Therapy Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Autologous Cell Therapy revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Autologous Cell Therapy revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• BioTime
• Pharmicell
• BrainStorm Cell Therapeutics
• Opexa Therapeutics
• Vericel Corporation
• Regeneus

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Autologous Cell Therapy Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Autologous Cell Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL AUTOLOGOUS CELL THERAPY OVERALL MARKET SIZE

2.1 Global Autologous Cell Therapy Market Size: 2021 VS 2028
2.2 Global Autologous Cell Therapy Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Autologous Cell Therapy Players in Global Market
3.2 Top Global Autologous Cell Therapy Companies Ranked by Revenue
3.3 Global Autologous Cell Therapy Revenue by Companies
3.4 Top 3 and Top 5 Autologous Cell Therapy Companies in Global Market, by Revenue in 2021
3.5 Global Companies Autologous Cell Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Autologous Cell Therapy Players in Global Market
  3.6.1 List of Global Tier 1 Autologous Cell Therapy Companies
  3.6.2 List of Global Tier 2 and Tier 3 Autologous Cell Therapy Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Autologous Cell Therapy Market Size Markets, 2021 & 2028
  4.1.2 Bone Marrow
  4.1.3 Epidermis
4.2 By Type - Global Autologous Cell Therapy Revenue & Forecasts
  4.2.1 By Type - Global Autologous Cell Therapy Revenue, 2017-2022
  4.2.2 By Type - Global Autologous Cell Therapy Revenue, 2023-2028
  4.2.3 By Type - Global Autologous Cell Therapy Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Autologous Cell Therapy Market Size, 2021 & 2028
  5.1.2 Neurology
  5.1.3 Orthopedics
  5.1.4 Cancer
  5.1.5 Wound Healing
  5.1.6 Other
5.2 By Application - Global Autologous Cell Therapy Revenue & Forecasts
  5.2.1 By Application - Global Autologous Cell Therapy Revenue, 2017-2022
  5.2.2 By Application - Global Autologous Cell Therapy Revenue, 2023-2028
  5.2.3 By Application - Global Autologous Cell Therapy Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Autologous Cell Therapy Market Size, 2021 & 2028
6.2 By Region - Global Autologous Cell Therapy Revenue & Forecasts
  6.2.1 By Region - Global Autologous Cell Therapy Revenue, 2017-2022
  6.2.2 By Region - Global Autologous Cell Therapy Revenue, 2023-2028
  6.2.3 By Region - Global Autologous Cell Therapy Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Autologous Cell Therapy Revenue, 2017-2028
  6.3.2 US Autologous Cell Therapy Market Size, 2017-2028
  6.3.3 Canada Autologous Cell Therapy Market Size, 2017-2028
  6.3.4 Mexico Autologous Cell Therapy Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Autologous Cell Therapy Revenue, 2017-2028
  6.4.2 Germany Autologous Cell Therapy Market Size, 2017-2028
  6.4.3 France Autologous Cell Therapy Market Size, 2017-2028
  6.4.4 U.K. Autologous Cell Therapy Market Size, 2017-2028
  6.4.5 Italy Autologous Cell Therapy Market Size, 2017-2028
  6.4.6 Russia Autologous Cell Therapy Market Size, 2017-2028
  6.4.7 Nordic Countries Autologous Cell Therapy Market Size, 2017-2028
  6.4.8 Benelux Autologous Cell Therapy Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Autologous Cell Therapy Revenue, 2017-2028
  6.5.2 China Autologous Cell Therapy Market Size, 2017-2028
  6.5.3 Japan Autologous Cell Therapy Market Size, 2017-2028
  6.5.4 South Korea Autologous Cell Therapy Market Size, 2017-2028
  6.5.5 Southeast Asia Autologous Cell Therapy Market Size, 2017-2028
  6.5.6 India Autologous Cell Therapy Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Autologous Cell Therapy Revenue, 2017-2028
  6.6.2 Brazil Autologous Cell Therapy Market Size, 2017-2028
  6.6.3 Argentina Autologous Cell Therapy Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Autologous Cell Therapy Revenue, 2017-2028
  6.7.2 Turkey Autologous Cell Therapy Market Size, 2017-2028
  6.7.3 Israel Autologous Cell Therapy Market Size, 2017-2028
  6.7.4 Saudi Arabia Autologous Cell Therapy Market Size, 2017-2028
  6.7.5 UAE Autologous Cell Therapy Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 BioTime
  7.1.1 BioTime Corporate Summary
  7.1.2 BioTime Business Overview
  7.1.3 BioTime Autologous Cell Therapy Major Product Offerings
  7.1.4 BioTime Autologous Cell Therapy Revenue in Global Market (2017-2022)
  7.1.5 BioTime Key News
7.2 Pharmicell
  7.2.1 Pharmicell Corporate Summary
  7.2.2 Pharmicell Business Overview
  7.2.3 Pharmicell Autologous Cell Therapy Major Product Offerings
  7.2.4 Pharmicell Autologous Cell Therapy Revenue in Global Market (2017-2022)
  7.2.5 Pharmicell Key News
7.3 BrainStorm Cell Therapeutics
  7.3.1 BrainStorm Cell Therapeutics Corporate Summary
  7.3.2 BrainStorm Cell Therapeutics Business Overview
  7.3.3 BrainStorm Cell Therapeutics Autologous Cell Therapy Major Product Offerings
  7.3.4 BrainStorm Cell Therapeutics Autologous Cell Therapy Revenue in Global Market (2017-2022)
  7.3.5 BrainStorm Cell Therapeutics Key News
7.4 Opexa Therapeutics
  7.4.1 Opexa Therapeutics Corporate Summary
  7.4.2 Opexa Therapeutics Business Overview
  7.4.3 Opexa Therapeutics Autologous Cell Therapy Major Product Offerings
  7.4.4 Opexa Therapeutics Autologous Cell Therapy Revenue in Global Market (2017-2022)
  7.4.5 Opexa Therapeutics Key News
7.5 Vericel Corporation
  7.5.1 Vericel Corporation Corporate Summary
  7.5.2 Vericel Corporation Business Overview
  7.5.3 Vericel Corporation Autologous Cell Therapy Major Product Offerings
  7.5.4 Vericel Corporation Autologous Cell Therapy Revenue in Global Market (2017-2022)
  7.5.5 Vericel Corporation Key News
7.6 Regeneus
  7.6.1 Regeneus Corporate Summary
  7.6.2 Regeneus Business Overview
  7.6.3 Regeneus Autologous Cell Therapy Major Product Offerings
  7.6.4 Regeneus Autologous Cell Therapy Revenue in Global Market (2017-2022)
  7.6.5 Regeneus Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Autologous Cell Therapy Market Opportunities & Trends in Global Market
Table 2. Autologous Cell Therapy Market Drivers in Global Market
Table 3. Autologous Cell Therapy Market Restraints in Global Market
Table 4. Key Players of Autologous Cell Therapy in Global Market
Table 5. Top Autologous Cell Therapy Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Autologous Cell Therapy Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Autologous Cell Therapy Revenue Share by Companies, 2017-2022
Table 8. Global Companies Autologous Cell Therapy Product Type
Table 9. List of Global Tier 1 Autologous Cell Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Autologous Cell Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Autologous Cell Therapy Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Autologous Cell Therapy Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Autologous Cell Therapy Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Autologous Cell Therapy Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Autologous Cell Therapy Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Autologous Cell Therapy Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Autologous Cell Therapy Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Autologous Cell Therapy Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Autologous Cell Therapy Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Autologous Cell Therapy Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Autologous Cell Therapy Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Autologous Cell Therapy Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Autologous Cell Therapy Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Autologous Cell Therapy Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Autologous Cell Therapy Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Autologous Cell Therapy Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Autologous Cell Therapy Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Autologous Cell Therapy Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Autologous Cell Therapy Revenue, (US$, Mn), 2023-2028
Table 30. BioTime Corporate Summary
Table 31. BioTime Autologous Cell Therapy Product Offerings
Table 32. BioTime Autologous Cell Therapy Revenue (US$, Mn), (2017-2022)
Table 33. Pharmicell Corporate Summary
Table 34. Pharmicell Autologous Cell Therapy Product Offerings
Table 35. Pharmicell Autologous Cell Therapy Revenue (US$, Mn), (2017-2022)
Table 36. BrainStorm Cell Therapeutics Corporate Summary
Table 37. BrainStorm Cell Therapeutics Autologous Cell Therapy Product Offerings
Table 38. BrainStorm Cell Therapeutics Autologous Cell Therapy Revenue (US$, Mn), (2017-2022)
Table 39. Opexa Therapeutics Corporate Summary
Table 40. Opexa Therapeutics Autologous Cell Therapy Product Offerings
Table 41. Opexa Therapeutics Autologous Cell Therapy Revenue (US$, Mn), (2017-2022)
Table 42. Vericel Corporation Corporate Summary
Table 43. Vericel Corporation Autologous Cell Therapy Product Offerings
Table 44. Vericel Corporation Autologous Cell Therapy Revenue (US$, Mn), (2017-2022)
Table 45. Regeneus Corporate Summary
Table 46. Regeneus Autologous Cell Therapy Product Offerings
Table 47. Regeneus Autologous Cell Therapy Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Autologous Cell Therapy Segment by Type in 2021
Figure 2. Autologous Cell Therapy Segment by Application in 2021
Figure 3. Global Autologous Cell Therapy Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Autologous Cell Therapy Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Autologous Cell Therapy Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Autologous Cell Therapy Revenue in 2021
Figure 8. By Type - Global Autologous Cell Therapy Revenue Market Share, 2017-2028
Figure 9. By Application - Global Autologous Cell Therapy Revenue Market Share, 2017-2028
Figure 10. By Region - Global Autologous Cell Therapy Revenue Market Share, 2017-2028
Figure 11. By Country - North America Autologous Cell Therapy Revenue Market Share, 2017-2028
Figure 12. US Autologous Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Autologous Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Autologous Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Autologous Cell Therapy Revenue Market Share, 2017-2028
Figure 16. Germany Autologous Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 17. France Autologous Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Autologous Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Autologous Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Autologous Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Autologous Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Autologous Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Autologous Cell Therapy Revenue Market Share, 2017-2028
Figure 24. China Autologous Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Autologous Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Autologous Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Autologous Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 28. India Autologous Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Autologous Cell Therapy Revenue Market Share, 2017-2028
Figure 30. Brazil Autologous Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Autologous Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Autologous Cell Therapy Revenue Market Share, 2017-2028
Figure 33. Turkey Autologous Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Autologous Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Autologous Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Autologous Cell Therapy Revenue, (US$, Mn), 2017-2028
Figure 37. BioTime Autologous Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Pharmicell Autologous Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. BrainStorm Cell Therapeutics Autologous Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Opexa Therapeutics Autologous Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Vericel Corporation Autologous Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Regeneus Autologous Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)